Friday, January 18, 2019 3:24:41 PM
Regarding Qapzola. I really believe that the phase III will show efficacy needed for approval. I don't have a problem with SPPI ultimately selling or out-licensing it, but I want it approved. I still think messing up Apaziquone was the biggest unforced error in SPPI's history. A billion dollar screw-up.
Agree that Focus is the game. Can't wait to see some combo data with Poziotinib.
Do you think MDACC will present at Feb 2019 IASLC?
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM